Global pharmaceutical giants make billions of dollars in Australia but pay a fraction of that in tax. They say the price they ...

As the country continues to deal with the fallout of the infamous Jeffery Epstein files, The Root is taking a closer look at ...

Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...

New York drugmaker Pfizer and Mainz, Germany, immunotherapy company BioNTech said the European Commission, which generally follows CHMP's advice, will now review the recommendation, with a final ...

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have gained a positive opinion from the European Medicines Agency’s Committee ...

In adults 18 years of age and older, Comirnaty Omicron XBB.1.5, Comirnaty JN.1 and Comirnaty KP.2 may be administered concomitantly with a pneumococcal conjugated vaccine (PCV). an unadjuvanted ...

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to 202 ...

The Trump administration is asking the Supreme Court to allow it to cut hundreds of millions of dollars’ worth of research ...

These five blue-chip dividend stocks have had a tough 2025 but are solid long-term buys for growth and income investors.

The chief engine of the U.S. economy lies in intangible investments, such as research and development, software, ...

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget ...